dipiperidinoethane-di-n-oxide has been researched along with Seizures in 2 studies
*Seizures: Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Collins, JF; De Gubareff, T; Olney, JW | 1 |
| Collins, RC; Olney, JW; Sloviter, RS | 1 |
2 other study(ies) available for dipiperidinoethane-di-n-oxide and Seizures
| Article | Year |
|---|---|
Dipiperidinoethane neurotoxicity clarified.
Topics: Amygdala; Animals; Biotransformation; Convulsants; Kainic Acid; Oxotremorine; Piperidines; Rats; Receptors, Cholinergic; Seizures; Structure-Activity Relationship | 1982 |
Excitotoxic mechanisms of epileptic brain damage.
Topics: Administration, Topical; Amygdala; Animals; Axons; Biomechanical Phenomena; Brain; Choline; Cholinesterase Inhibitors; Convulsants; Corpus Striatum; Epilepsy; Folic Acid; Injections; Kainic Acid; Lithium; Motor Cortex; Neural Pathways; Neurotoxins; Piperidines; Rats; Seizures; Somatosensory Cortex | 1986 |